<DOC>
	<DOCNO>NCT02550977</DOCNO>
	<brief_summary>The purpose study look effectiveness new investigational medication apply transdermal patch . The patch apply skin study medication absorb skin suppress ovarian activity therefore prevent egg leave ovary ( ovulation ) . The study look study drug ` safety well tolerated absorption , breakdown elimination body . It describe body affect specific drug administration .</brief_summary>
	<brief_title>Russia/Ukraine Suppression Ovarian Activity Study</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Gestodene</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Healthy female subject request contraception Aged 18 35 year ( inclusive ) ; smoker must older 30 year Normal clinically insignificant cervical smear require followup History regular cyclic menstrual period Willingness use nonhormonal method contraception entire study Proven ovulation upon completion pretreatment cycle Pregnancy lactation Obesity ( body mass index [ BMI ] &gt; 30.0 kg/m2 ) Significant skin reaction transdermal preparation sensitivity surgical/medical tape Any disease condition may worsen hormonal treatment Use hormonal contraception study medication study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Contraception</keyword>
	<keyword>Transdermal contraceptive patch</keyword>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Pharmacokinetic</keyword>
</DOC>